Quintiles Transnational Holdings (Q) Announces Quarterly Results
Quintiles Transnational Holdings (NYSE:Q) posted its quarterly earnings results on Thursday. The company reported $0.65 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.60 by $0.05, American Banking News.com reports. The company had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter in the prior year, the company posted $0.50 earnings per share. The company’s quarterly revenue was up 9.6% on a year-over-year basis. Quintiles Transnational Holdings updated its FY14 guidance to $2.57-2.67 EPS.
A number of analysts have recently weighed in on Q shares. Analysts at SunTrust initiated coverage on shares of Quintiles Transnational Holdings in a research note on Tuesday, June 24th. They set a “neutral” rating and a $56.00 price target on the stock. On a related note, analysts at Jefferies Group initiated coverage on shares of Quintiles Transnational Holdings in a research note on Wednesday, June 4th. They set a “hold” rating and a $54.00 price target on the stock. Finally, analysts at Credit Suisse reiterated an “outperform” rating on shares of Quintiles Transnational Holdings in a research note on Tuesday, May 6th. They now have a $56.00 price target on the stock, down previously from $60.00. Four research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $55.42.
Shares of Quintiles Transnational Holdings (NYSE:Q) traded down 5.51% during mid-day trading on Thursday, hitting $53.69. The stock had a trading volume of 487,578 shares. Quintiles Transnational Holdings has a 52-week low of $40.10 and a 52-week high of $57.33. The stock has a 50-day moving average of $53.95 and a 200-day moving average of $51.31. The company has a market cap of $6.987 billion and a P/E ratio of 27.85.
Quintiles Transnational Holdings Inc is a provider of biopharmaceutical development services and commercial outsourcing services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.